Take Solutions Limited - Asset Resilience Ratio
Take Solutions Limited (TAKE) has an Asset Resilience Ratio of 41.29% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Take Solutions Limited (TAKE) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2025)
This chart shows how Take Solutions Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Take Solutions Limited assets under control.
Liquid Assets Composition Over Time
This chart breaks down Take Solutions Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore TAKE long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs1.50 Million | 0.43% |
| Short-term Investments | Rs143.90 Million | 40.87% |
| Total Liquid Assets | Rs145.40 Million | 41.29% |
Asset Resilience Insights
- Very High Liquidity: Take Solutions Limited maintains exceptional liquid asset reserves at 41.29% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Take Solutions Limited Industry Peers by Asset Resilience Ratio
Compare Take Solutions Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
Biotechnology | 63.98% |
|
Tango Therapeutics Inc
NASDAQ:TNGX |
Biotechnology | 62.24% |
|
Damora Therapeutics, Inc.
NASDAQ:DMRA |
Biotechnology | 0.00% |
|
Wecome Pharmaceutical Co Ltd
SHE:300878 |
Biotechnology | 0.67% |
|
Tectonic Therapeutic, Inc.
NASDAQ:TECX |
Biotechnology | 86.66% |
|
Relmada Therapeutics Inc
NASDAQ:RLMD |
Biotechnology | 95.25% |
|
MediWound Ltd
F:M8W |
Biotechnology | 56.04% |
Annual Asset Resilience Ratio for Take Solutions Limited (2002–2025)
The table below shows the annual Asset Resilience Ratio data for Take Solutions Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 8.10% | Rs29.54 Million ≈ $319.46K |
Rs364.79 Million ≈ $3.95 Million |
+8.09pp |
| 2024-03-31 | 0.00% | Rs40.00K ≈ $432.58 |
Rs881.05 Million ≈ $9.53 Million |
-4.79pp |
| 2023-03-31 | 4.80% | Rs107.60 Million ≈ $1.16 Million |
Rs2.24 Billion ≈ $24.27 Million |
+2.42pp |
| 2022-03-31 | 2.38% | Rs290.71 Million ≈ $3.14 Million |
Rs12.23 Billion ≈ $132.27 Million |
+2.36pp |
| 2021-03-31 | 0.02% | Rs2.77 Million ≈ $29.96K |
Rs18.45 Billion ≈ $199.49 Million |
-0.23pp |
| 2020-03-31 | 0.25% | Rs60.99 Million ≈ $659.58K |
Rs24.83 Billion ≈ $268.55 Million |
-9.50pp |
| 2019-03-31 | 9.75% | Rs2.28 Billion ≈ $24.60 Million |
Rs23.34 Billion ≈ $252.40 Million |
-5.18pp |
| 2018-03-31 | 14.93% | Rs2.75 Billion ≈ $29.76 Million |
Rs18.44 Billion ≈ $199.38 Million |
+14.51pp |
| 2017-03-31 | 0.41% | Rs56.92 Million ≈ $615.57K |
Rs13.73 Billion ≈ $148.45 Million |
+0.28pp |
| 2016-03-31 | 0.14% | Rs16.70 Million ≈ $180.60K |
Rs12.14 Billion ≈ $131.34 Million |
-0.01pp |
| 2015-03-31 | 0.15% | Rs13.50 Million ≈ $146.00K |
Rs9.22 Billion ≈ $99.75 Million |
-5.67pp |
| 2014-03-31 | 5.81% | Rs501.50 Million ≈ $5.42 Million |
Rs8.62 Billion ≈ $93.27 Million |
-0.18pp |
| 2013-03-31 | 5.99% | Rs501.60 Million ≈ $5.42 Million |
Rs8.37 Billion ≈ $90.50 Million |
-0.78pp |
| 2012-03-31 | 6.77% | Rs501.60 Million ≈ $5.42 Million |
Rs7.41 Billion ≈ $80.10 Million |
-1.74pp |
| 2011-03-31 | 8.51% | Rs500.00 Million ≈ $5.41 Million |
Rs5.88 Billion ≈ $63.54 Million |
-3.68pp |
| 2010-03-31 | 12.19% | Rs626.01 Million ≈ $6.77 Million |
Rs5.13 Billion ≈ $55.52 Million |
+1.28pp |
| 2009-03-31 | 10.92% | Rs562.23 Million ≈ $6.08 Million |
Rs5.15 Billion ≈ $55.70 Million |
+1.67pp |
| 2008-03-31 | 9.25% | Rs367.88 Million ≈ $3.98 Million |
Rs3.98 Billion ≈ $43.03 Million |
+5.93pp |
| 2007-03-31 | 3.31% | Rs85.61 Million ≈ $925.82K |
Rs2.58 Billion ≈ $27.95 Million |
+1.20pp |
| 2006-03-31 | 2.11% | Rs19.08 Million ≈ $206.34K |
Rs905.33 Million ≈ $9.79 Million |
-4.13pp |
| 2005-03-31 | 6.24% | Rs12.16 Million ≈ $131.51K |
Rs194.89 Million ≈ $2.11 Million |
+3.44pp |
| 2004-03-31 | 2.80% | Rs3.96 Million ≈ $42.83K |
Rs141.45 Million ≈ $1.53 Million |
+2.06pp |
| 2003-03-31 | 0.74% | Rs700.00K ≈ $7.57K |
Rs94.72 Million ≈ $1.02 Million |
-0.77pp |
| 2002-03-31 | 1.51% | Rs450.00K ≈ $4.87K |
Rs29.90 Million ≈ $323.36K |
-- |
About Take Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient c… Read more